Massachusetts S3034 establishes comprehensive PFAS (per- and polyfluoroalkyl substances) restrictions and remediation programs across environmental, agricultural, consumer product, and food safety domains. Key provisions include: a PFAS Remediation Trust Fund for drinking water and groundwater cleanup; prohibitions on intentionally added PFAS in food packaging (effective January 1, 2028), priority consumer products like cookware and children's products (effective January 1, 2029), and Class B firefighting foam (effective January 1, 2029); a complete ban on biosolids application and biosolids-containing fertilizers; creation of agricultural relief and fertilizer purchasing funds for farmers harmed by PFAS contamination; mandatory disclosure platforms for PFAS-containing products; and requirements for industrial discharge permits to implement PFAS best management practices. The bill also mandates sludge management master planning, private well testing and treatment assistance programs, and multilingual public awareness campaigns focused on environmental justice populations.

Why It Matters to MAHA

This bill aligns with MAHA's mission of clean food and agriculture by eliminating PFAS-contaminated biosolids from farmland and restricting PFAS in food packaging and consumer products. The biosolids ban particularly advances health freedom by removing a major source of persistent chemical contamination from the agricultural supply chain. The bill prioritizes environmental justice populations in remediation and outreach, expanding access to clean water and safe food. Transparency requirements mandating manufacturer registration of PFAS-containing products empower consumers with information to make informed health choices. Agricultural relief provisions protect farmer autonomy and livelihoods against contamination from external sources. By restricting intentionally added PFAS across priority consumer products and establishing rigorous monitoring and disclosure mechanisms, the bill removes harmful chemicals from commerce while preserving legitimate uses through a transparent exemption process, embodying MAHA principles of removing regulatory barriers that protect health rather than restrict choice.